PARIS, Oct 6 (Reuters) – France’s health authority (HAS) is recommending a third COVID-19 vaccine booster shot for health workers, it said in a statement on Wednesday.
https://youtu.be/JZgFTnpGmpM
New York’s largest healthcare provider fires 1,400 unvaccinated workers
(Reuters) – New York State’s largest healthcare provider, Northwell Health, has fired 1,400 employees who refused to get COVID-19 vaccinations, according to a spokesman, Joe Kemp. As with other healthcare companies that have recently terminated workers for not complying with vaccine mandates, the fired employees represent a small percentage of Northwell’s workforce of more than 76,000, all of whom are now inoculated. New York’s vaccination mandate for healthcare workers went into effect last week. Several other states, including California, have imposed similar measures. Officials have credited the requirements with increasing the rate of vaccination, though a small number of employees have decided they would rather lose their jobs than get shots https://www.reuters.com/world/us/few-skeptical-us-hospital-workers-choose-dismissal-over-vaccine-2021-10-03. Northwell announced its vaccine mandate in August, weeks before the state requirement. The company’s mandate extended to both clinical and non-clinical workers. “Our goal was not to terminate employees,” Kemp said. “Our goal was to get people vaccinated.” Kemp said the terminations will have no impact on patient care at Northwell’s 23 hospitals and other facilities. “Northwell regrets losing any employee under such circumstances,” the company said in a statement. “We owe it to our staff, our patients and the communities we serve to be 100 percent vaccinated against COVID-19.”
Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months – study
Pfizer-BioNTech’s COVID-19 vaccine is notably less effective six months after the second dose is administered, a new study finds. Researchers from King’s College London in the UK analyzed COVID-19 testing data and found the vaccine’s effectiveness falls from 88 percent to 77 percent after five to six months. They could not determine whether the lower effectiveness caused an increase in hospitalizations or deaths. The findings could spell trouble in the U.S., where more than 100 million people have received at least one dose of the vaccine – especially as the Indian ‘Delta’ variant continues to spread, causing cases to surge. Federal officials hope that plans to administer boosters in September – pending approval from the U.S. Food and Drug Administration (FDA) will help shore up protection. The British study, published last week, included 1.2 million participants who had received either the Pfizer or AstraZeneca vaccines. While not available for emergency use in the U.S., the AstraZeneca vaccine is widely used across Europe. More than 400,000 participants in the study had been vaccinated with the Pfizer vaccine by July 3. Britain was hit by a third wave of infections during this period after the more infectious Delta variant sparked outbreaks across the country. ZOE, a health data science company that contributed to the study, built an app that would ask users to report daily on whether they are unwell, their symptoms and if they have tested positive for the virus. Using data gathered from the app and Covid testing, researchers determined that a month after vaccination, the vaccine was 88 percent effective. That figure falls to 74 percent after five to six months. NB: Research show the vaccine effectiveness after 8 months falls to 30 to 40 percent. Antivaccers are going crazy. Hello we all new from the start that the vaccines wears off and new variants pop up. No one is jumping off a bridge because the Flu vaccine requires a yearly jab.
Continue reading “Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months – study”
Amid COVID-19 booster data dilemma, EU nations’ plans diverge
LONDON (Reuters) – A patchwork of campaigns for an extra COVID-19 shot are being rolled out across the European Union even before the region’s drug watchdog rules on whether they are safe and effective.
Italy, France, Germany and Ireland have already started to administer booster shots and the Netherlands plans to do so soon but only to people who are immuno-suppressed. Continue reading “Amid COVID-19 booster data dilemma, EU nations’ plans diverge”
US: 158,284 new cases, death toll tops 700,000
The United States reached another grim milestone on Friday, as the confirmed coronavirus death toll topped 700,000, just over a year and a half into the pandemic, and despite the wide availability of vaccines. The milestone, according to data from Johns Hopkins University, comes less than two weeks after the national death toll surpassed the estimated number of fatalities in the U.S. during the 1918 influenza pandemic. Despite national COVID-19 metrics showing encouraging signs of decline, approximately 1,500 Americans are dying from the virus every day, according to federal data. “Reaching 700,000 deaths is a tragic and completely avoidable milestone. We had the knowledge and the tools to prevent this from happening, and unfortunately politics, lack of urgency and mistrust in science got us here,” said John Brownstein, Ph.D., an epidemiologist at Boston Children’s Hospital and ABC News contributor. Continue reading “US: 158,284 new cases, death toll tops 700,000”
‘This is a profound game changer’: Merck’s antiviral pill cuts risk of COVID-19 hospitalization and death in half, data show
Former FDA head says Merck’s oral pill could become a powerful tool in combating COVID in high-risk patients who are already symptomatic. Merck cheered investors and healthcare experts alike on Friday with the news that its COVID-19 antiviral cut the risk of hospitalization or death by roughly half in a late-stage trial, and could become a powerful tool in reining in the pandemic. Continue reading “‘This is a profound game changer’: Merck’s antiviral pill cuts risk of COVID-19 hospitalization and death in half, data show”
Radio Free Wall Street
Remdesivir Shows A Lot Of Promise In Clinical Studies
A new study reveals that myocarditis cases may be because the jab hits a vein.
Wall Street turns green on COVID drug Molnupiravir optimism
Israel reports very few myocarditis cases after Pfizer boosters… Urgent Aspirating the syringe when getting shot
JERUSALEM, Oct 1 (Reuters) – Israel’s Health Ministry has identified fewer than 10 cases of heart inflammation following a third dose of the Pfizer/BioNtech vaccine among millions administered, according to recently released data.
Continue reading “Israel reports very few myocarditis cases after Pfizer boosters… Urgent Aspirating the syringe when getting shot”
YouTube blocks all anti-vaccine content… That in their sole discretion deem untrue…
YouTube on Wednesday announced it is banning “harmful vaccine content” from the platform, a long-awaited shift that vastly expands its existing policy on medical misinformation. The new rules explicitly ban content that makes false claims about any “currently administered vaccines that are approved and confirmed to be safe and effective” by local health authorities and the World Health Organization.
Continue reading “YouTube blocks all anti-vaccine content… That in their sole discretion deem untrue…”